Skip to main content

Wang Lab

The Wang lab is interested in developing drug leads/candidates for kinase, phosphate kinase and protein targets identified by UNC faculty and external investigators. We have successfully used the structure- and/or ligand-based drug design approaches to deliver compounds to clinic (MerTK inhibitors such as MRX-2843) or licensing (IDH1 inhibitor, co-developed with NCATs). We will continue to apply the similar approaches for drug discovery towards new targets.

 

xiaodong_wang

Xiaodong Wang, PhD

Associate Professor, Chemical Biology and Medicinal Chemistry
Director of Medicinal Chemistry
xiaodonw@unc.edu

 

 

 

Deyu Kong, PhD

Postdoc
deyu2@email.unc.edu

 

 

Kaikai Lyu, PhD

Postdoc
kaikail2@unc.edu

 

 

Dilipkumar Uredi, PhD

Postdoc
duredi@unc.edu